https://m2.mtmt.hu/ eng 2026-04-15 02:25 JournalArticle 34889417 APPROVED true Online kiadás 2024 0 false 2026-03-19T13:33:23.500+0000 2026-02-19T13:58:43.948+0000 2024-05-29T16:16:33.705+0000 true 10026589 Tichy Rita /api/admin/10026589 Admin Rita Tichy (SE_KK_Admin5_TR, admin) true 10026589 2026-03-27T10:20:52.953+0000 2026-03-27T10:20:52.953+0000 Admin 10014568 /api/admin/10014568 Andrea Vándor (VA, admin) Vándor Andrea true 10014568 true 2025-02-03T20:57:33.368+0000 true false true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle true 1134514 Survey paper true 24 24 /api/publicationtype/24 PublicationType Journal Article 1 true 24 JournalArticle /api/subtype/1134514 Összefoglaló cikk SubType Survey paper (Journal Article) 102 true 1134514 true 1 /api/category/1 Category Scientific true 1 Chen, Yu Hua true true /api/journal/825 REVIEWED BRITISH JOURNAL OF PHARMACOLOGY 0007-1188 1476-5381 true false 825 false 825 true 0007-1188 1476-5381 Journal FOREIGN 183 6 1271 1287 1271 17 2026 The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies. While ICIs have shown high anti‐cancer efficacy, they also have characteristic side effects, termed immune‐related adverse events (irAEs). These side effects hinder the therapeutic potential of ICIs and, therefore, finding ways to prevent and treat them is of paramount importance. The current protocols to manage irAEs follow an empirical route of steroid administration and, in more severe cases, ICI withdrawal. However, this approach is not optimal in many cases, as there are often steroid‐refractory irAEs, and there is a potential for corticosteroid use to promote tumour progression. This review surveys the current alternative approaches to the treatments for irAEs, with the goal of summarizing and highlighting the best attempts to treat irAEs, without compromising anti‐tumour immunity and allowing for rechallenge with ICIs after resolution of the irAEs. Funding 2040702 /api/funding/2040702 (LP-2021-14) false true Funding 2041076 /api/funding/2041076 (RRF-2.3.1-21-2022-0000) false true true 2024 true true true false true false NONE 2026-03-19 false 8 0 8 7 1 8 8 8 6 8 8 7 7 7 1 0 8 7 8 7 0 4 4 Folyóiratcikk Journal Article 24 8 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2025 0 8 7 8 7 D1 false 10028393 false false false 2024-06-26T09:13:25.034+0000 Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); HCEMM-SE Kardiometabolikus Immunológia Kutatócs... (SE / AOK / I / FFI); MTA-SE Momentum Kardio-Onkológia és Kardioimmun... (SE / AOK / I / FFI); MTA-SE Rendszerfarmakológiai Kutatócsoport (SE / AOK / I / FFI) 4 21 4 4 0 true 10014568 Language 10002 /api/language/10002 English Angol English true 2 true PersonAuthorship 116853450 /api/authorship/116853450 Chen, Yu Hua [Chen, Yu Hua (Gyógyszerészet), author] Department of Pharmacology and Pharmacotherapy (SU / FM / I) 1 0.25 true false false Author 10095585 /api/author/10095585 Yu Hua Chen (Gyógyszerészet) Chen Yu Hua true true Chen Yu Hua true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 116853451 /api/authorship/116853451 Kovács, Tamás* [Kovács, Tamás (Molekuláris orvos...), author] Department of Pharmacology and Pharmacotherapy (SU / FM / I); HCEMM-SU Cardiometabolic Immunology Research Group (SU / FM / I / DPP); MTA-SE Momentum Cardio-Oncology and Cardioimmun... (SU / FM / I / DPP) 2 0.25 true false false Author 10060030 /api/author/10060030 Tamás Kovács (Molekuláris orvostudományok) Kovács Tamás true 10060030 true Kovács Tamás true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 116853452 /api/authorship/116853452 Ferdinandy, Péter [Ferdinandy, Péter (Farmakológia, mol...), author] Department of Pharmacology and Pharmacotherapy (SU / FM / I) 3 0.25 false false false Author 10010125 /api/author/10010125 Péter Ferdinandy (Farmakológia, molekuláris medicina) Ferdinandy Péter true 10010125 true Ferdinandy Péter true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PersonAuthorship 116853453 /api/authorship/116853453 Varga, Zoltán V. ✉ [Varga, Zoltán (kardiovaszkuláris...), author] Department of Pharmacology and Pharmacotherapy (SU / FM / I); MTA-SE System Pharmacology Research Group (SU / FM / I / DPP); HCEMM-SU Cardiometabolic Immunology Research Group (SU / FM / I / DPP); MTA-SE Momentum Cardio-Oncology and Cardioimmun... (SU / FM / I / DPP) 4 0.25 false true true Author 10028393 /api/author/10028393 Zoltán Varga (kardiovaszkuláris kutatás) Varga Zoltán true 10028393 true Varga Zoltán V. true false false AuthorshipType 1 /api/authorshiptype/1 Author 0 true 0 true false true PublicationIdentifier 26277238 /api/publicationidentifier/26277238 DOI: 10.1111/bph.16405 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.1111/bph.16405 https://doi.org/10.1111/bph.16405 false true PublicationIdentifier 26416979 /api/publicationidentifier/26416979 WoS: 001232023400001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001232023400001 https://www.webofscience.com/wos/woscc/full-record/001232023400001 true true PublicationIdentifier 26546432 /api/publicationidentifier/26546432 Scopus: 85194824208 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85194824208 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85194824208 true true PublicationIdentifier 26277239 /api/publicationidentifier/26277239 PubMed: 38803135 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 38803135 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=38803135&dopt=Abstract false true PublicationIdentifier 31512319 /api/publicationidentifier/31512319 Other URL: https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.16405 PlainSource 40 /api/publicationsource/40 Other URL PublicationSourceType 10006 /api/publicationsourcetype/10006 Link true true true Egyéb URL Other URL @@@ true true 40 true IDENTICAL https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.16405 https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.16405 false true SjrRating 11716270 /api/sjrrating/11716270 sjr:D1 (2026) Scopus - Pharmacology BRITISH JOURNAL OF PHARMACOLOGY 0007-1188 1476-5381 13 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 3004 /api/classificationexternal/3004 Scopus - Pharmacology true 3004 true D1 FROM_PREVIOUS_TO_LAST_YEAR true true Reference 53723976 /api/reference/53723976 1. DOI: 10.3390/cancers13050989 1 10.3390/cancers13050989 false true Reference 53723977 /api/reference/53723977 2. DOI: 10.1111/bph.16180 2 10.1111/bph.16180 false true Reference 53723978 /api/reference/53723978 3. DOI: 10.1111/bph.16176 3 10.1111/bph.16176 false true Reference 53723979 /api/reference/53723979 4. DOI: 10.1111/imj.93_13578 4 10.1111/imj.93_13578 false true Reference 53723980 /api/reference/53723980 5. DOI: 10.1002/ijc.32132 5 10.1002/ijc.32132 false true Reference 53723981 /api/reference/53723981 6. DOI: 10.1200/JCO.2023.41.16_suppl.9566 6 10.1200/JCO.2023.41.16_suppl.9566 false true Reference 53723982 /api/reference/53723982 7. DOI: 10.1016/j.carpath.2020.107211 7 10.1016/j.carpath.2020.107211 false true Reference 53723983 /api/reference/53723983 8. DOI: 10.1007/s00262-017-1962-6 8 10.1007/s00262-017-1962-6 false true Reference 53723984 /api/reference/53723984 9. DOI: 10.1038/s41467-017-02358-7 9 10.1038/s41467-017-02358-7 false true Reference 53723985 /api/reference/53723985 10. DOI: 10.1053/j.gastro.2020.10.029 10 10.1053/j.gastro.2020.10.029 false true Reference 53723986 /api/reference/53723986 11. DOI: 10.1093/annonc/mdv182 11 10.1093/annonc/mdv182 false true Reference 53723987 /api/reference/53723987 12. DOI: 10.3390/curroncol30070502 12 10.3390/curroncol30070502 false true Reference 53723988 /api/reference/53723988 13. DOI: 10.1038/s41467-022-27960-2 13 10.1038/s41467-022-27960-2 false true Reference 53723989 /api/reference/53723989 14. DOI: 10.1093/eurheartj/ehab618 14 10.1093/eurheartj/ehab618 false true Reference 53723990 /api/reference/53723990 15. DOI: 10.1161/CIRCULATIONAHA.120.049981 15 10.1161/CIRCULATIONAHA.120.049981 false true Reference 53723991 /api/reference/53723991 16. DOI: 10.1136/jitc-2023-007307 16 10.1136/jitc-2023-007307 false true Reference 53723992 /api/reference/53723992 17. DOI: 10.2147/CMAR.S218756 17 10.2147/CMAR.S218756 false true Reference 53723993 /api/reference/53723993 18. DOI: 10.1161/CIRCULATIONAHA.117.030571 18 10.1161/CIRCULATIONAHA.117.030571 false true Reference 53723994 /api/reference/53723994 19. DOI: 10.1056/NEJMc1903064 19 10.1056/NEJMc1903064 false true Reference 53723995 /api/reference/53723995 20. DOI: 10.1111/bph.15984 20 10.1111/bph.15984 false true Reference 53723996 /api/reference/53723996 21. DOI: 10.1016/j.annonc.2022.10.001 21 10.1016/j.annonc.2022.10.001 false true Reference 53723997 /api/reference/53723997 22. DOI: 10.1016/j.ccell.2022.04.004 22 10.1016/j.ccell.2022.04.004 false true Reference 53723998 /api/reference/53723998 23. DOI: 10.1056/NEJMoa1003466 23 10.1056/NEJMoa1003466 false true Reference 53723999 /api/reference/53723999 24. DOI: 10.1016/j.jemermed.2018.07.005 24 10.1016/j.jemermed.2018.07.005 false true Reference 53724000 /api/reference/53724000 25. DOI: 10.1136/jitc-2023-008482 25 10.1136/jitc-2023-008482 false true Reference 53724001 /api/reference/53724001 26. DOI: 10.1097/CJI.0000000000000239 26 10.1097/CJI.0000000000000239 false true Reference 53724002 /api/reference/53724002 27. DOI: 10.1056/NEJMoa1609214 27 10.1056/NEJMoa1609214 false true Reference 53724003 /api/reference/53724003 28. DOI: 10.1186/s40425-018-0412-0 28 10.1186/s40425-018-0412-0 false true Reference 53724004 /api/reference/53724004 29. DOI: 10.1002/jgh3.12868 29 10.1002/jgh3.12868 false true Reference 53724005 /api/reference/53724005 30. DOI: 10.3892/mco.2021.2227 30 10.3892/mco.2021.2227 false true Reference 53724006 /api/reference/53724006 31. DOI: 10.3389/fendo.2023.1161768 31 10.3389/fendo.2023.1161768 false true Reference 53724007 /api/reference/53724007 32. DOI: 10.1007/s11912-020-00925-8 32 10.1007/s11912-020-00925-8 false true Reference 53724008 /api/reference/53724008 33. DOI: 10.1097/CAD.0000000000001162 33 10.1097/CAD.0000000000001162 false true Reference 53724009 /api/reference/53724009 34. DOI: 10.7326/0003-4819-138-10-200305200-00008 34 10.7326/0003-4819-138-10-200305200-00008 false true Reference 53724010 /api/reference/53724010 35. DOI: 10.1056/NEJMoa1504030 35 10.1056/NEJMoa1504030 false true Reference 53724011 /api/reference/53724011 36. DOI: 10.4049/jimmunol.2200244 36 10.4049/jimmunol.2200244 false true Reference 53724012 /api/reference/53724012 37. DOI: 10.1016/j.jaccao.2022.11.008 37 10.1016/j.jaccao.2022.11.008 false true Reference 53724013 /api/reference/53724013 38. DOI: 10.1016/j.bbrc.2017.02.128 38 10.1016/j.bbrc.2017.02.128 false true Reference 53724014 /api/reference/53724014 39. DOI: 10.1136/jitc-2022-005841 39 10.1136/jitc-2022-005841 false true Reference 53724015 /api/reference/53724015 40. DOI: 10.1002/cam4.5438 40 10.1002/cam4.5438 false true Reference 53724016 /api/reference/53724016 41. DOI: 10.1177/1078155220947141 41 10.1177/1078155220947141 false true Reference 53724017 /api/reference/53724017 42. DOI: 10.1016/S1470-2045(18)30457-1 42 10.1016/S1470-2045(18)30457-1 false true Reference 53724018 /api/reference/53724018 43. DOI: 10.1016/j.jacc.2018.02.037 43 10.1016/j.jacc.2018.02.037 false true Reference 53724019 /api/reference/53724019 44. DOI: 10.1186/s40959-021-00114-x 44 10.1186/s40959-021-00114-x false true Reference 53724020 /api/reference/53724020 45. DOI: 10.1016/j.ejca.2015.11.016 45 10.1016/j.ejca.2015.11.016 false true Reference 53724021 /api/reference/53724021 46. DOI: 10.1038/ni.1817 46 10.1038/ni.1817 false true Reference 53724022 /api/reference/53724022 47. DOI: 10.1210/clinem/dgab263 47 10.1210/clinem/dgab263 false true Reference 53724023 /api/reference/53724023 48. DOI: 10.1136/jitc-2022-004699 48 10.1136/jitc-2022-004699 false true Reference 53724024 /api/reference/53724024 49. DOI: 10.1016/j.alit.2022.01.001 49 10.1016/j.alit.2022.01.001 false true Reference 53724025 /api/reference/53724025 50. DOI: 10.1097/CMR.0b013e32835fb524 50 10.1097/CMR.0b013e32835fb524 false true Reference 53724026 /api/reference/53724026 51. DOI: 10.1007/s40265-022-01723-1 51 10.1007/s40265-022-01723-1 false true Reference 53724027 /api/reference/53724027 52. DOI: 10.1007/s11912-018-0718-6 52 10.1007/s11912-018-0718-6 false true Reference 53724028 /api/reference/53724028 53. DOI: 10.1056/NEJMra1703481 53 10.1056/NEJMra1703481 false true Reference 53724029 /api/reference/53724029 54. Reynolds K. 2022: Regular and young investigator award abstracts, p. A726, DOI: 10.1136/jitc-2022-SITC2022.0696 54 10.1136/jitc-2022-SITC2022.0696 false true Reference 53724030 /api/reference/53724030 55. DOI: 10.1159/000494569 55 10.1159/000494569 false true Reference 53724031 /api/reference/53724031 56. DOI: 10.1002/ejhf.2289 56 10.1002/ejhf.2289 false true Reference 53724032 /api/reference/53724032 57. DOI: 10.1056/NEJMc1901677 57 10.1056/NEJMc1901677 false true Reference 53724033 /api/reference/53724033 58. DOI: 10.1038/nrgastro.2018.14 58 10.1038/nrgastro.2018.14 false true Reference 53724034 /api/reference/53724034 59. DOI: 10.1200/JCO.21.01440 59 10.1200/JCO.21.01440 false true Reference 53724035 /api/reference/53724035 60. DOI: 10.1212/CPJ.0000000000000772 60 10.1212/CPJ.0000000000000772 false true Reference 53724036 /api/reference/53724036 61. DOI: 10.1158/1078-0432.CCR-09-0287 61 10.1158/1078-0432.CCR-09-0287 false true Reference 53724037 /api/reference/53724037 62. DOI: 10.1136/gutjnl-2018-316948 62 10.1136/gutjnl-2018-316948 false true Reference 53724038 /api/reference/53724038 63. DOI: 10.1177/1078155217745144 63 10.1177/1078155217745144 false true Reference 53724039 /api/reference/53724039 64. DOI: 10.3389/fphar.2023.1349081 64 10.3389/fphar.2023.1349081 false true Reference 53724040 /api/reference/53724040 65. DOI: 10.1001/jamadermatol.2021.5476 65 10.1001/jamadermatol.2021.5476 false true Reference 53724041 /api/reference/53724041 66. DOI: 10.1056/NEJMoa2109970 66 10.1056/NEJMoa2109970 false true Reference 53724042 /api/reference/53724042 67. DOI: 10.1200/JCO.2014.57.4756 67 10.1200/JCO.2014.57.4756 false true Reference 53724043 /api/reference/53724043 68. DOI: 10.1111/cup.12876 68 10.1111/cup.12876 false true Reference 53724044 /api/reference/53724044 69. DOI: 10.3390/biology12030472 69 10.3390/biology12030472 false true Reference 53724045 /api/reference/53724045 70. DOI: 10.1007/s11886-017-0835-0 70 10.1007/s11886-017-0835-0 false true Reference 53724046 /api/reference/53724046 71. DOI: 10.1001/jamaoncol.2018.3923 71 10.1001/jamaoncol.2018.3923 false true Reference 53724047 /api/reference/53724047 72. DOI: 10.3389/fimmu.2023.1071983 72 10.3389/fimmu.2023.1071983 false true Reference 53724048 /api/reference/53724048 73. DOI: 10.1007/s10555-021-09976-0 73 10.1007/s10555-021-09976-0 false true Reference 53724049 /api/reference/53724049 74. DOI: 10.3389/fimmu.2022.944013 74 10.3389/fimmu.2022.944013 false true Reference 53724050 /api/reference/53724050 75. DOI: 10.3389/fimmu.2023.1167975 75 10.3389/fimmu.2023.1167975 false true /api/publication/34889417 Chen Yu Hua et al. Treatment options for immune-related adverse events associated with immune checkpoint inhibitors. (2026) BRITISH JOURNAL OF PHARMACOLOGY 0007-1188 1476-5381 183 6 1271-1287<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10095585"><a href="/gui2/?type=authors&mode=browse&sel=10095585" target="_blank">Chen Yu Hua (<span class="authorship-author-name">Chen Yu Hua</span> <span class="authorAux-mtmt"> Gyógyszerészet</span>) </a> </span> <span class="author-affil"><span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Instituties">I</span>/Department of Pharmacology and Pharmacotherapy</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10060030"><a href="/gui2/?type=authors&mode=browse&sel=10060030" target="_blank">Kovács Tamás^* (<span class="authorship-author-name">Kovács Tamás</span> <span class="authorAux-mtmt"> Molekuláris orvostudományok</span>) </a> </span> <span class="author-affil"><span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Instituties">I</span>/Department of Pharmacology and Pharmacotherapy; <span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Instituties">I</span>/<span title="Department of Pharmacology and Pharmacotherapy">DPP</span>/HCEMM-SU Cardiometabolic Immunology Research Group; <span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Instituties">I</span>/<span title="Department of Pharmacology and Pharmacotherapy">DPP</span>/MTA-SE Momentum Cardio-Oncology and Cardioimmunology Research Group</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10010125"><a href="/gui2/?type=authors&mode=browse&sel=10010125" target="_blank">Ferdinandy Péter (<span class="authorship-author-name">Ferdinandy Péter</span> <span class="authorAux-mtmt"> Farmakológia, molekuláris medicina</span>) </a> </span> <span class="author-affil"><span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Instituties">I</span>/Department of Pharmacology and Pharmacotherapy</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10028393"><a href="/gui2/?type=authors&mode=browse&sel=10028393" target="_blank">Varga Zoltán V. ✉ (<span class="authorship-author-name">Varga Zoltán</span> <span class="authorAux-mtmt"> kardiovaszkuláris kutatás</span>) </a> </span> <span class="author-affil"><span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Instituties">I</span>/Department of Pharmacology and Pharmacotherapy; <span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Instituties">I</span>/<span title="Department of Pharmacology and Pharmacotherapy">DPP</span>/MTA-SE System Pharmacology Research Group; <span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Instituties">I</span>/<span title="Department of Pharmacology and Pharmacotherapy">DPP</span>/HCEMM-SU Cardiometabolic Immunology Research Group; <span title="Semmelweis University">SU</span>/<span title="Faculty of Medicine">FM</span>/<span title="Instituties">I</span>/<span title="Department of Pharmacology and Pharmacotherapy">DPP</span>/MTA-SE Momentum Cardio-Oncology and Cardioimmunology Research Group</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;34889417" target="_blank">Treatment options for immune-related adverse events associated with immune checkpoint inhibitors</a></div> <div> <span class="journal-title">BRITISH JOURNAL OF PHARMACOLOGY</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/0007-1188">0007-1188</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1476-5381">1476-5381</a>)</span>: <span class="journal-volume">183</span> <span class="journal-issue">6</span> <span class="page"> pp 1271-1287 </span> <span class="year">(2026)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Language: English | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1111/bph.16405" target="_blank" href="https://doi.org/10.1111/bph.16405"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001232023400001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001232023400001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85194824208" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85194824208"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="38803135" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=38803135&dopt=Abstract"> PubMed </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.16405" target="_blank" href="https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.16405"> Other URL </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Journal subject: Scopus - Pharmacology&nbsp;&nbsp;&nbsp;Rank:&nbsp;D1</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="" class="citingPub-count">Citing papers: 8</span> | Independent citation: 7 | Self citation: 1 | Unknown citation: 0 | Number of citations in WoS: 8 | Number of citations in Scopus:&nbsp;6 | WoS/Scopus assigned:&nbsp;8 | Number of citations with DOI:&nbsp;8 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;34889417&sort=publishedYear,desc&sort=title"> Number of cited publications: 4 </a> </div> <div class="mtid"><span class="long-pub-mtid">Publication: 34889417</span> | <span class="status-data status-APPROVED"> Published </span> Core Citing | <span class="type-subtype">Journal Article ( Survey paper ) </span> | <span class="pub-category">Scientific</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> (LP-2021-14), (RRF-2.3.1-21-2022-0000) </div> <div class="lastModified">Last Modified: 2026.02.19. 14:58 Éva Pécsi (MTMT Közp 2,3, admin) </div> <div class="lockedBy">Centrally managed 2025.02.03. 21:57 Andrea Vándor (VA, admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Comments</u>: Online kiadás 2024</pre> </div></div>